Fig. 2

Evolution of PET radiotracer uptakes. a Representative images of a tumour-bearing mouse injected with [¹⁸F]FDG prior to treatment (left) and after 5 days (right) of sunitinib (lower part) or DMSO (upper part) administration (B: bladder, H: heart, T: tumour). b Tumour [¹⁸F]FDG SUV evolution for both 5 day-treated (n = 4) and control (n = 3) groups. c PET longitudinal images of a grafted mice injected with [¹⁸F]FMISO before treatment (left) and after 6 days (right) of treatment with sunitinib (bottom) or DMSO only (top) (I: intestine, T: tumour). d Tumour [¹⁸F]FMISO uptake evolution for both 6 day-treated (n = 3) and control (n = 3) groups